New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation-Reference-Cited by-同舟云学术

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

Published:2017-11-21 Issue:3 Volume:18 Page:413-421
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Fabbri C,Tansey K E,Perlis R H,Hauser J,Henigsberg N^ORCID,Maier W,Mors O,Placentino A,Rietschel M,Souery D,Breen G^ORCID,Curtis C,Sang-Hyuk L,Newhouse S,Patel H,Guipponi M,Perroud N,Bondolfi G,O'Donovan M,Lewis G,Biernacka J M,Weinshilboum R M,Farmer A,Aitchison K J,Craig I,McGuffin P,Uher R,Lewis C M

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201744.pdf

Reference79 articles.

1. Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310: 591–608.

2. Bradvik L, Mattisson C, Bogren M, Nettelbladt P . Long-term suicide risk of depression in the Lundby cohort 1947-1997—severity and gender. Acta Psychiatr Scand 2008; 117: 185–191.

3. Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J et al. Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand 2006; 113: 492–500.

4. Sobocki P, Jonsson B, Angst J, Rehnberg C . Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87–98.

5. Fabbri C, Di Girolamo G, Serretti A . Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. Am J Med Geneti B Neuropsychiatr Genet 2013; 162B: 487–520.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry;Biological Psychiatry;2024-10

2. Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets?;European Archives of Psychiatry and Clinical Neuroscience;2024-08-27

3. Baseline gut microbiota profiles affect treatment response in patients with depression;Frontiers in Microbiology;2024-07-03

4. Research hotspots and trends in the relationship between genetics and major depressive disorder: A scientometric analysis from 2003 to 2023;Medicine;2023-12-22

5. PharmGScore scores of compound genetic variant burden for psychiatric treatment optimization;2023-06-29